Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, by prescription, ...

Doyle (Antitrust & Foreign Investment Partner, UK Co-Head of Technology Sector, and Co-Head of Games and Interactive ...

Signaloid ( a company providing hardware and cloud-based computing solutions for running workloads ranging from quantitative finance computations, to engineering simulations, and Bayesian AI models, ...